Connect your AI

Vericel VCEL Operating Lease Liabilities

Operating Lease Liabilities at other companies

LeMaitre VascularLMAT

$17.5M+18.7%

Capricor TherapeuticsCAPR

$13.94M+3,323%

Globus MedicalGMED

$100.1M+22.5%

Other financials

Income statement

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

Market cap$2.06B-26.8%

Enterprise value$2.05B-28.0%

P/E96.1×-850×

P/S7.1×-4.7×

Profitability

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Vericel's operating lease liabilities?: Vericel (VCEL) reported operating lease liabilities of $80.36M in Q1 2026.
How has Vericel's operating lease liabilities changed year-over-year?: Vericel's operating lease liabilities decreased by 8.5% year-over-year, from $87.8M to $80.36M.
What is the long-term trend for Vericel's operating lease liabilities?: Over 5 years (2020 to 2025), Vericel's operating lease liabilities has grown at a 11.0% compound annual growth rate (CAGR), from $48.79M to $82.28M.
What does operating lease liabilities mean?: Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.